Sodium Iodide + Monobasic Calcium Phosphate + ChlorocresolThird Party Manufacturing in India

Sodium Iodide in combination with Monobasic Calcium Phosphate and Chlorocresol works as a sclerosing agent by chemically irritating the endothelial lining of the vein wall. When injected into a varicose vein, it triggers a controlled inflammatory response that damages the endothelial cells of the tunica intima and the inner layers of the tunica media.

This targeted endothelial damage leads to the formation of a fibrous scar tissue within the vein lumen, a process known as endofibrosis. The scar tissue seals off the abnormal vein, causing it to collapse and eventually be reabsorbed by the body. Blood flow is then redirected to healthier deeper veins.

Unlike surgical stripping or laser ablation, this chemical sclerotherapy approach allows for targeted treatment of varicose veins, reticular veins, and telangiectasias without incisions. The combination of Sodium Iodide as the active irritant with Monobasic Calcium Phosphate as a stabilizing buffer and Chlorocresol as an antimicrobial preservative creates a stable, ready-to-use formulation for vascular intervention.

Therapeutic Uses

Sodium Iodide + Monobasic Calcium Phosphate + Chlorocresol injection is used for:

• Varicose Veins: Sclerotherapy of lower extremity superficial varicose veins to induce vein fibrosis and closure.
• Reticular Veins: Treatment of medium-sized blue-green reticular veins that are not suitable for laser therapy.
• Telangiectasias (Spider Veins): Sclerotherapy for cosmetically distressing spider veins and thread veins.
• Venous Malformations: Used off-label for certain venous vascular malformations.

Why Manufacturers Choose This Combination

Chemical sclerotherapy is a well-established, minimally invasive procedure that remains the gold standard for treating superficial venous insufficiency. This combination offers a ready-to-use injectable solution that is stable and effective. With the rising prevalence of venous disease and increasing demand for non-surgical cosmetic and therapeutic options, this sclerosing agent has consistent demand in both surgical and dermatological practice.

This makes the Sodium Iodide sclerotherapy combination a valuable product for third party manufacturing in India, serving both therapeutic vascular clinics and the medical aesthetics market.